AERI
Aerie Pharmaceuticals
AERI
AERI
Delisted
AERI was delisted on the 18th of November, 2022.
155 hedge funds and large institutions have $712M invested in Aerie Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 55 increasing their positions, 54 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
56% less call options, than puts
Call options by funds: $572K | Put options by funds: $1.29M
83% less funds holding in top 10
Funds holding in top 10: 6 → 1 (-5)
Holders
155
Holding in Top 10
1
Calls
$572K
Puts
$1.29M
Top Buyers
| 1 | +$20.3M | |
| 2 | +$19.8M | |
| 3 | +$17.4M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$11M |
| 5 |
Morgan Stanley
New York
|
+$7.54M |
Top Sellers
| 1 | -$83M | |
| 2 | -$30.1M | |
| 3 | -$8.69M | |
| 4 |
First Manhattan
New York
|
-$7.79M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$6.84M |